Financial Ratios Ping An Insurance (Group) Company of China, Ltd.
Equities
601318
CNE000001R84
Life & Health Insurance
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.60 CNY | -1.52% |
|
-0.77% | -9.94% |
| 12/03 | Logistics firm GLP seeks $20 billion valuation in planned Hong Kong IPO, sources say | RE |
| 16/02 | Lufax Renews Services Agreement With Controlling Shareholder | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.51 | 1.07 | 0.75 | 0.8 | 1.01 | |||||
Return on Total Capital | 5.51 | 3.88 | 2.83 | 3.14 | 4.17 | |||||
Return On Equity % | 17.32 | 11.79 | 9.54 | 9.05 | 11.58 | |||||
Return on Common Equity | 19.93 | 12.9 | 10.03 | 9.69 | 13.85 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 32.53 | 30.18 | 27.23 | 30.17 | 34.01 | |||||
SG&A Margin | 13.54 | 13.74 | 13.69 | 8.84 | 8.35 | |||||
EBITDA Margin % | 16.88 | 14 | 11.45 | 17.46 | 21.86 | |||||
EBITA Margin % | 16.32 | 13.35 | 10.54 | 16.08 | 20.78 | |||||
EBIT Margin % | 16.24 | 13.26 | 10.45 | 15.97 | 20.68 | |||||
Income From Continuing Operations Margin % | 12.07 | 9.58 | 8.8 | 12.05 | 15.23 | |||||
Net Income Margin % | 10.84 | 7.99 | 6.86 | 9.45 | 13.14 | |||||
Net Avail. For Common Margin % | 10.84 | 7.99 | 6.86 | 9.45 | 13.14 | |||||
Normalized Net Income Margin | 7.77 | 5.27 | 3.48 | 5.67 | 8.97 | |||||
Levered Free Cash Flow Margin | 4.74 | 0.87 | -5.4 | -11.66 | -40.46 | |||||
Unlevered Free Cash Flow Margin | 5.99 | 2.25 | -4.23 | -9.98 | -38.75 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.15 | 0.13 | 0.11 | 0.08 | 0.08 | |||||
Fixed Assets Turnover | 20.95 | 20.12 | 18.75 | 14.35 | 16.43 | |||||
Receivables Turnover (Average Receivables) | 12.81 | 13.87 | 16.19 | - | - | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.32 | 1.31 | 1.36 | 1.75 | 1.8 | |||||
Quick Ratio | 1.13 | 1.12 | 1.18 | 1.57 | 1.65 | |||||
Operating Cash Flow to Current Liabilities | 0.16 | 0.04 | 0.22 | 0.21 | 0.19 | |||||
Days Sales Outstanding (Average Receivables) | 28.56 | 26.32 | 22.54 | - | - | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | 70.07 | 76.42 | 84.89 | 5.58 | 4.71 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 169.71 | 156.66 | 144.25 | 135.56 | 135.55 | |||||
Total Debt / Total Capital | 62.92 | 61.04 | 59.06 | 57.55 | 57.55 | |||||
LT Debt/Equity | 121.26 | 117.63 | 108.8 | 106.91 | 90.43 | |||||
Long-Term Debt / Total Capital | 44.96 | 45.83 | 44.55 | 45.38 | 38.39 | |||||
Total Liabilities / Total Assets | 89.63 | 89.37 | 89.45 | 89.39 | 89.93 | |||||
EBIT / Interest Expense | 8.11 | 6.01 | 5.57 | 5.95 | 7.55 | |||||
EBITDA / Interest Expense | 8.71 | 6.57 | 6.37 | 6.7 | 8.17 | |||||
(EBITDA - Capex) / Interest Expense | 8.33 | 6.14 | 5.98 | 6.38 | 7.92 | |||||
Total Debt / EBITDA | 7.28 | 9.15 | 11.63 | 10.21 | 8.2 | |||||
Net Debt / EBITDA | 5.95 | 7.26 | 9.21 | 8.27 | 6.43 | |||||
Total Debt / (EBITDA - Capex) | 7.61 | 9.79 | 12.39 | 10.73 | 8.47 | |||||
Net Debt / (EBITDA - Capex) | 6.22 | 7.77 | 9.81 | 8.68 | 6.64 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.97 | -3.66 | -4.14 | 2.51 | 6.26 | |||||
Gross Profit, 1 Yr. Growth % | 2.75 | -10.63 | -13.73 | 0.73 | 19.78 | |||||
EBITDA, 1 Yr. Growth % | 4.18 | -20.08 | -21.52 | -9.28 | 27.27 | |||||
EBITA, 1 Yr. Growth % | 4.04 | -21.21 | -24.24 | -10.73 | 30.91 | |||||
EBIT, 1 Yr. Growth % | 4.05 | -21.31 | -24.4 | -10.79 | 31.12 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -3.05 | -23.57 | -11.8 | -18.95 | 34.28 | |||||
Net Income, 1 Yr. Growth % | -4.22 | -28.99 | -17.56 | -22.83 | 47.79 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.84 | -33.67 | -36.65 | -21.01 | 67.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -4.06 | -28.86 | -17.31 | -24.4 | 47.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.68 | 2.38 | 3.59 | -9.12 | -5.09 | |||||
Inventory, 1 Yr. Growth % | - | - | - | - | - | |||||
Accounts Receivable, 1 Yr. Growth % | 14.06 | -15.07 | -9.46 | - | - | |||||
Total Assets, 1 Yr. Growth % | 15.87 | 6.45 | 9.81 | 5.21 | 11.87 | |||||
Common Equity, 1 Yr. Growth % | 13.28 | 6.54 | 5.7 | 3.43 | 3.29 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.5 | 6.54 | 2.06 | 3.92 | 3.93 | |||||
Cash From Operations, 1 Yr. Growth % | 25.11 | -71.12 | 439.2 | -24.41 | 6.12 | |||||
Capital Expenditures, 1 Yr. Growth % | -18.14 | 21.92 | -27.2 | -11.96 | -14.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -117.13 | -95.05 | -595.83 | -69.53 | 268.63 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -122.42 | -88.03 | -267.35 | -72.8 | 333.78 | |||||
Dividend Per Share, 1 Yr. Growth % | 7.32 | 8.18 | 1.68 | 0.41 | 4.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.17 | 0.09 | -3.85 | -15.6 | 4.37 | |||||
Gross Profit, 2 Yr. CAGR % | 7.04 | -4.17 | -12.03 | -15.71 | 9.84 | |||||
EBITDA, 2 Yr. CAGR % | 1.73 | -8.76 | -20.81 | -5.7 | 9.86 | |||||
EBITA, 2 Yr. CAGR % | 1.3 | -9.47 | -22.74 | -7.3 | 10.72 | |||||
EBIT, 2 Yr. CAGR % | 1.34 | -9.52 | -22.87 | -7.35 | 10.79 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 15.02 | -13.92 | -17.89 | -5.28 | 4.33 | |||||
Net Income, 2 Yr. CAGR % | 15.43 | -17.53 | -23.49 | -8.18 | 6.8 | |||||
Normalized Net Income, 2 Yr. CAGR % | 7.33 | -18.82 | -35.18 | -12.39 | 15.18 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.66 | -17.38 | -23.3 | -8.97 | 5.59 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 17.33 | 0.33 | 2.98 | -2.98 | -7.13 | |||||
Inventory, 2 Yr. CAGR % | - | - | - | - | - | |||||
Accounts Receivable, 2 Yr. CAGR % | 18.32 | -1.58 | -12.31 | -99.39 | - | |||||
Total Assets, 2 Yr. CAGR % | 15.49 | 11.06 | 8.12 | 6.87 | 8.49 | |||||
Common Equity, 2 Yr. CAGR % | 17.06 | 9.86 | 6.12 | 5.2 | 3.36 | |||||
Tangible Book Value, 2 Yr. CAGR % | 17.4 | 10.45 | 4.28 | 3.69 | 3.92 | |||||
Cash From Operations, 2 Yr. CAGR % | 23 | -39.89 | 24.78 | 99.98 | -10.43 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.18 | -0.1 | -5.79 | -19.94 | -13.24 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -34.3 | -82.64 | -45.52 | 182.03 | 5.98 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -18.21 | -71.55 | -53.49 | 71.33 | 5.91 | |||||
Dividend Per Share, 2 Yr. CAGR % | 13.1 | 7.75 | 4.88 | 1.04 | 2.65 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.51 | 5.99 | -1.31 | -11.76 | -8.86 | |||||
Gross Profit, 3 Yr. CAGR % | 10.73 | 0.79 | -7.36 | -13.95 | -5.24 | |||||
EBITDA, 3 Yr. CAGR % | 12.49 | -6.14 | -13.23 | -10.76 | 5.76 | |||||
EBITA, 3 Yr. CAGR % | 12.59 | -6.84 | -14.69 | -12.19 | 5.67 | |||||
EBIT, 3 Yr. CAGR % | 12.77 | -6.86 | -14.78 | -12.26 | 5.71 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.81 | 0.37 | -13.22 | -11.82 | 6.4 | |||||
Net Income, 3 Yr. CAGR % | 17.11 | -1.83 | -17.54 | -15.72 | 7.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.85 | -9.03 | -25.26 | -20.15 | 8.83 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.23 | -1.64 | -17.36 | -16.15 | 6.91 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.89 | 12.12 | 1.4 | -1.22 | -3.69 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | - | - | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.18 | 5.94 | -4.28 | -96.86 | - | |||||
Total Assets, 3 Yr. CAGR % | 13.64 | 12.4 | 10.64 | 6.73 | 8.51 | |||||
Common Equity, 3 Yr. CAGR % | 17.23 | 13.44 | 8.45 | 5.64 | 4.56 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.19 | 13.66 | 7.58 | 4.63 | 3.77 | |||||
Cash From Operations, 3 Yr. CAGR % | 37.03 | -24.12 | 24.89 | 4.92 | 61.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | -19.64 | 4.55 | -10.1 | -7.89 | -18.17 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -16.58 | -57.66 | -43.49 | -21.91 | 208.36 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -7.1 | -37.72 | -47.3 | -27.61 | 129.61 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.62 | 11.43 | 5.69 | 3.37 | 2.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.65 | 10.37 | 4.53 | -3.22 | -5.36 | |||||
Gross Profit, 5 Yr. CAGR % | 10.75 | 7.28 | 0.99 | -6.1 | -4.74 | |||||
EBITDA, 5 Yr. CAGR % | 15.42 | 9.63 | -2.25 | -5.96 | -0.31 | |||||
EBITA, 5 Yr. CAGR % | 15.44 | 9.38 | -3.16 | -7.03 | -0.66 | |||||
EBIT, 5 Yr. CAGR % | 15.62 | 9.52 | -3.13 | -7.06 | -0.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.58 | 10.97 | 1.45 | -1.93 | -2.24 | |||||
Net Income, 5 Yr. CAGR % | 21.43 | 10.25 | -1.22 | -4.42 | -3.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.7 | 6.46 | -10.34 | -10.39 | -3.21 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.95 | 10.39 | -1.06 | -4.64 | -3.56 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.18 | 9.76 | 7.07 | 5.82 | -2.1 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.5 | 17.71 | 9.61 | -86.55 | - | |||||
Total Assets, 5 Yr. CAGR % | 14.86 | 12.71 | 11.39 | 10.15 | 9.52 | |||||
Common Equity, 5 Yr. CAGR % | 17.93 | 16.2 | 12.65 | 10.07 | 6.65 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19.27 | 18.35 | 12.99 | 9.57 | 6.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 18.14 | -16.93 | 31.99 | 11.81 | 8.92 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.57 | -6.02 | -14.36 | -6.04 | -11.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -17.42 | -47.09 | -9.36 | -6.11 | 1.31 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -14.15 | -36.39 | -12.15 | -5.2 | 1.14 | |||||
Dividend Per Share, 5 Yr. CAGR % | 32.93 | 25.98 | 10.04 | 7.16 | 4.46 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















